Andrew D. Berti
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antimicrobial Resistance in Staphylococcus 19
- Clostridium difficile and Clostridium perfringens research 3
-
- Bacterial biofilms and quorum sensing 7
- Co-authors
- Michael G. Thomas (4 shared papers)Warren E. Rose (14 shared papers)George Sakoulas (9 shared papers)Matthew D. McMahon (1 shared paper)Emily E. Jackson (1 shared paper)Yolande A. Chan (1 shared paper)Victor Nizet (6 shared papers)Quin H. Christensen (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (10 papers)Antibiotics (4 papers)Open Forum Infectious Diseases (3 papers)Journal of Bacteriology (2 papers)Molecular Pharmaceutics (1 paper)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Andrew D. Berti
27 papers receiving 968 citations
Peers
Comparison fields: 5 of 82
- Molecular Medicine 154
- Clinical Biochemistry 186
- Pharmacology 364
- Infectious Diseases 382
- Microbiology 69
Countries citing papers authored by Andrew D. Berti
This map shows the geographic impact of Andrew D. Berti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Berti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Berti more than expected).
Fields of papers citing papers by Andrew D. Berti
This network shows the impact of papers produced by Andrew D. Berti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Berti. The network helps show where Andrew D. Berti may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew D. Berti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 232 | |
| 2 | 2007 | 96 | |
| 3 | 2012 | 92 | |
| 4 | 2007 | 80 | |
| 5 | 2009 | 69 | |
| 6 | 2013 | 64 | |
| 7 | 2012 | 52 | |
| 8 | 2015 | 45 | |
| 9 | 2017 | 39 | |
| 10 | 2015 | 28 | |
| 11 | 2018 | 24 | |
| 12 | 2013 | 24 | |
| 13 | 2017 | 22 | |
| 14 | 2020 | 20 | |
| 15 | 2016 | 18 | |
| 16 | 2020 | 13 | |
| 17 | 2015 | 13 | |
| 18 | 2021 | 10 | |
| 19 | 2019 | 10 | |
| 20 | 2022 | 7 |
About Andrew D. Berti
Andrew D. Berti is a scholar working on Infectious Diseases, Molecular Biology, Epidemiology, Clinical Biochemistry and Molecular Medicine, having authored 29 papers that have together received 989 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (19 papers), Bacterial biofilms and quorum sensing (7 papers), Bacterial Identification and Susceptibility Testing (7 papers), Antibiotic Resistance in Bacteria (6 papers), Infective Endocarditis Diagnosis and Management (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Clostridium difficile and Clostridium perfringens research (3 papers) and Plant-Microbe Interactions and Immunity (2 papers). The work is most often cited by research in Molecular Medicine (154 citations), Clinical Biochemistry (186 citations), Pharmacology (364 citations), Infectious Diseases (382 citations) and Microbiology (69 citations). Andrew D. Berti has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Michael G. Thomas, Warren E. Rose, George Sakoulas, Matthew D. McMahon, Emily E. Jackson, Yolande A. Chan, Victor Nizet, Quin H. Christensen, Sanjay K. Shukla and Paul R. Hutson. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Antibiotics, Open Forum Infectious Diseases, Journal of Bacteriology and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.